Micronized Progesterone vs Synthetic Progestins

If you have a uterus, estrogen therapy needs a progestogen, and which one you take affects early side effects and some long-term risk. The main choice is between micronized progesterone, which is the same molecule your body made, and synthetic progestins, a family of molecules built to protect the womb lining but which behave differently elsewhere. A hormonal IUD is another route.

Why estrogen needs a progestogen

Estrogen stimulates the lining of the uterus. Unopposed, over years, that raises the risk of endometrial hyperplasia and cancer several-fold. A progestogen keeps the lining thin or sheds it on a schedule, and with one in place the endometrial risk returns to baseline. That is its job in hormone therapy; everything else it does is a side effect, good or bad.

Women who have had a hysterectomy don’t need one and usually take estrogen alone, which has the most favourable breast-risk profile of any regimen. The exceptions are a history of endometriosis, where residual tissue can respond to estrogen, and some cases after surgery for endometrial cancer; a clinician decides those.

Progesterone and progestins

Progesterone is the hormone your ovaries produced after ovulation. Micronized progesterone is that molecule, milled fine enough to absorb when swallowed, usually in a capsule with peanut oil (there are peanut-free preparations). It’s bioidentical in the real sense, and it’s FDA-approved.

Progestins are synthetic molecules engineered to act on the progesterone receptor in the womb lining. The common ones in US hormone therapy are medroxyprogesterone acetate (the progestin in the 2002 Women’s Health Initiative trial), norethindrone acetate (in some combined patches and pills), levonorgestrel (in hormonal IUDs) and drospirenone. Because they were built for potency on the lining, they’re reliable there; because they’re not progesterone, they interact differently with breast tissue, mood, lipids and androgen receptors.

Comparison

	Micronized progesterone	Synthetic progestins	Levonorgestrel IUD
Bioidentical	Yes	No	No
Lining protection	Adequate at standard doses with standard estrogen doses	Strong	Strong, delivered locally
Breast cancer risk	Lower than progestins in large observational studies; not raised in the first several years	Higher, particularly medroxyprogesterone acetate in WHI and E3N	Limited data; systemic exposure is low
Blood pressure, lipids	Neutral	Some raise blood pressure or worsen lipids	Minimal systemic effect
Mood	Calming for most; low mood in a minority	Low mood and irritability more common, especially androgenic progestins	Low systemic effect; mood effects reported by some
Sleep	Mildly sedating, which helps	Neutral	Neutral
Skin and hair	Neutral	Androgenic ones (norethindrone, levonorgestrel) can cause acne and worsen hair thinning	Low systemic effect
Bleeding control in perimenopause	Modest	Good	Excellent; often stops periods
Contraception	No	No (at HT doses)	Yes
How taken	Capsule at bedtime; vaginal use off-label	Pill, or combined in a patch	Fitted in person, lasts years

The breast-risk difference is the reason micronized progesterone has become the default. In the French E3N cohort and later analyses, estrogen with micronized progesterone showed little or no increase in breast cancer risk in the first several years of use, while estrogen with synthetic progestins did. These are observational data, not a head-to-head trial, so they’re a strong signal rather than proof, and The Menopause Society’s position statement reflects that.

Regimens: cyclic or continuous

• Cyclic. Progesterone for 12 to 14 days a month (usually 200 mg micronized), producing a planned bleed at the end of each course. Used in perimenopause and the first year or so after menopause, when a continuous regimen would cause irregular spotting. Some women prefer it long-term because the progestogen-free days feel better.
• Continuous. A lower daily dose (100 mg micronized) every night with the estrogen, aiming for no bleeding. The usual choice after about a year post-menopause. Irregular spotting is common for the first three to six months and then settles; see HRT side effects in the first weeks.
• IUD. Continuous local protection for several years, no pills; see perimenopause: HRT or the pill for why it suits women still cycling.

If progesterone causes side effects

A minority of women feel worse on the progestogen than before treatment: low mood, anxiety, bloating, breast pain or headaches that track the days it’s taken. These symptoms often come from the progestogen rather than the estrogen, and they do not always mean you need to stop hormone therapy:

1. Switch to micronized progesterone if you’re on a synthetic progestin. This often helps.
2. Take it at bedtime. This can make drowsiness easier to manage and may reduce the flat daytime feeling.
3. Use it vaginally. Off-label, but widely used: the same capsule inserted at night protects the lining with much less reaching the brain and breast. For some women this is the difference between tolerating hormone therapy and not.
4. Change the regimen. A cyclic regimen gives you progestogen-free days. A levonorgestrel IUD is another option and keeps most progestogen out of the bloodstream.

Do not skip the progestogen while keeping systemic estrogen. Over-the-counter “natural progesterone cream” does not deliver enough to protect the lining.

Which progestogen fits?

For most women with a uterus, micronized progesterone at bedtime is the starting choice. Use it continuously if you’re past menopause and cyclically if you’re still in the transition. A levonorgestrel IUD may fit if you’re perimenopausal and need bleeding control or contraception, or if oral progestogens don’t agree with you. A synthetic progestin may fit when a combined product is practical, such as a patch that pairs estradiol with norethindrone, or when bleeding control matters and an IUD isn’t wanted. Use estrogen alone if you’ve had a hysterectomy, unless your clinician says otherwise.

At Golden Leaf Health, micronized progesterone is the usual starting choice, taken at night, with the regimen matched to where you are in the transition. The IUD route is arranged with an in-person clinician when it’s the better tool. Book a first visit if you’re starting hormone therapy or struggling with the progestogen you’re on.

Sources: The Menopause Society, 2022 hormone therapy position statement; ACOG, Hormone therapy for menopause; FDA, Prometrium prescribing information; Mayo Clinic, Hormone therapy: is it right for you?.